A detailed history of Cullen/Frost Bankers, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 119 shares of NTRA stock, worth $20,018. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119
Previous 119 -0.0%
Holding current value
$20,018
Previous $12,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$85.28 - $112.6 $10,148 - $13,399
119 New
119 $12,000
Q4 2020

Feb 08, 2021

SELL
$66.66 - $111.74 $666 - $1,117
-10 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$45.89 - $72.67 $458 - $726
10 New
10 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.